[
  {
    "ts": null,
    "headline": "Zoetis (ZTS) Gains Positive Opinion For Portela Therapy In EU For Cat OA Pain Relief",
    "summary": "Zoetis (ZTS) recently received a positive opinion from the European Medicines Agency's CVMP for its pain relief therapy, Portela, expected to enhance its product line for feline osteoarthritis. The company also secured a new $1.25 billion revolving credit facility to bolster its financial flexibility. These developments come amid a mixed market environment where the Nasdaq reached new highs. Despite these advancements, Zoetis' stock declined 3% last month, reflecting broader market dynamics...",
    "url": "https://finnhub.io/api/news?id=b9bb86c93f5a15a765093dd88a3b93759f84c2d21d3a46536ec35dee627b1e6d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757788308,
      "headline": "Zoetis (ZTS) Gains Positive Opinion For Portela Therapy In EU For Cat OA Pain Relief",
      "id": 136736156,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "Zoetis (ZTS) recently received a positive opinion from the European Medicines Agency's CVMP for its pain relief therapy, Portela, expected to enhance its product line for feline osteoarthritis. The company also secured a new $1.25 billion revolving credit facility to bolster its financial flexibility. These developments come amid a mixed market environment where the Nasdaq reached new highs. Despite these advancements, Zoetis' stock declined 3% last month, reflecting broader market dynamics...",
      "url": "https://finnhub.io/api/news?id=b9bb86c93f5a15a765093dd88a3b93759f84c2d21d3a46536ec35dee627b1e6d"
    }
  }
]